Management of Acute Uncomplicated UTIs in Adults by Community Pharmacists

NCT05399797 | Unknown

• 1 other identifier: taofiqclinical
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This study is to be conducted in community pharmacies. It involves the use of trained mystery patients to evaluate community pharmacists at baseline and post intervention. The pharmacists will be divided into control and intervention groups using computer generated codes. Those in the intervention group will receive an online training by clinical pharmacists. The training will employ the use of didactic teaching and the use of case studies and simulations covering the diagnosis and management of acute uncomplicated urinary tract infections in adults. Post intervention, mystery patients will revisit the community pharmacists in the control and intervention groups for re-assessment.

Conditions

Urinary Tract Infections; Urinary Tract Infection Lower Acute

Keywords

Urinary Tract Infections; Pharmacist; Mystery Patient

Outcome Measures

Primary Outcomes (3)

• Questioning skill score

  Expert Panels' Relevant Questions - Through 80% consensus the expert panel picked 50 relevant questions. The minimum score is "0" and the maximum score is "50". The higher the score the better the questioning skill.

  Through the study completion (an average of 6 months)

• Correct diagnosis of Acute Uncomplicated Urinary Tract Infection

  using the Infectious Disease Society of America treatment guideline, the pharmacists should be able to reach a diagnosis of Acute Uncomplicated Urinary Tract Infection. Appropriate diagnosis will be classified as "Correct diagnosis" and inappropriate diagnosis will be classified as "Incorrect diagnosis". Proportion will be used to describe the number of community pharmacists who got the diagnosis Correct and Incorrect.

  Through the study completion (an average of 6 months)

• Appropriate management of urinary tract infection

  Infectious Disease Society of America treatment guideline

  Through the study completion (an average of 6 months)

Study Arms (2)

Pharmacists in the intervention group

EXPERIMENTAL

The pharmacist will be given an online educational training on management of acute uncomplicated urinary tract infections

Other: Educational training

Pharmacists in the control group

NO INTERVENTION

pharmacists in this group will not be trained, until after the completion of the study.

Interventions

Educational training OTHER

Pharmacists in the intervention group will given detailed online educational training on how to recognize and manage acute uncomplicated urinary tract infections in adults.

Pharmacists in the intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The superintendent pharmacist, or the pharmacist manager or any other post National Youth Service Corps pharmacist

You may not qualify if:

• Interns, and pharmacists undergoing the mandatory National Youth Service Corps program.

Sponsors & Collaborators

• University of Ibadan: lead

Study Sites (1)

University of Ibadan

Ibadan, Oyo State, 200284, Nigeria

RECRUITING

MeSH Terms

Conditions

Urinary Tract Infections

Interventions

Training Support

Condition Hierarchy (Ancestors)

Infections; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Financial Support; Economics; Health Care Economics and Organizations

Study Officials

• Segun J Showande, Ph.D.

  University of Ibadan

  STUDY CHAIR

Central Study Contacts

Abdulhafiz T Taofiq, B.Pharm.

CONTACT

+2347063798732; taofiq32@gmail.com

Segun J Showande, Ph.D.

CONTACT

+2348027887608; pharmsegg@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: The participating pharmacists, the mystery patient and the investigator will not know who is in the control or the intervention group
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: The pharmacists in the interventional group will receive educational training after baseline assessment while those in the control group will receive the same training at the end of the study

Study Record Dates

• First Submitted: May 7, 2022
• First Posted: June 1, 2022
• Study Start: March 21, 2022
• Primary Completion: September 1, 2022
• Study Completion: November 1, 2022
• Last Updated: June 1, 2022

Record last verified: 2022-05

Data Sharing

• IPD Sharing: Will not share

Locations

NG (1)